San Diego, California – June 3rd, 2024 – CQDM, in collaboration with Axelys, Fonds de recherche du Québec, Génome Québec, and Médicament Québec, announces the launch of the CELLULE, a new model to support and finance the development of promising technologies based on the use of RNA. This announcement is to be made at the…
CQDM. We share.Canadian health science companies are invited to submit an expression of interest to pitch in person to global investors at the 2024 OBIO® Investment Summit (OIS) in Toronto on February 14–16, 2024.Selected Canadian health science companies seeking their next raise and demonstrating high growth potential and readiness for investment will pitch virtually to…
$50 million to support biotech companies. In order to ensure the continuity of the financing chain for the life sciences sector, the government of Quebec announces the renewal of BioMed Propulsion. This will be allocated an envelope of $50 million to support biotechnology and medical technology companies which have already reached the early stages of their…
AI and drug development.An interesting conference discussing artificial intelligence and drug development. Come hear Yoshua Bengio discuss AI advances in the field at the next adMare BioInnovations ‘Global Leaders’ series event.-Thursday, October 5, at noon (EST)-Online webinar-RSVP: https://www.admarebio.com/en/events-details/detail/admare-global-leader-series-featuring-yoshua-bengio/45424
Congratulations Université Laval. A large-scale international collaborative study lead by Professor Jacques Simard from Université Laval and Professor Douglas Easton at the University of Cambridge, UK, has identified new genes associated with breast cancer that could eventually be included in tests to identify women at increased risk. The study found evidence for at least four…
Laval, Canada – (BUSINESSWIRE) – April 13, 2023 – BIOQuébec, CQDM, Fonds de solidarité FTQ and adMare BioInnovations, co-organizers of Sweet Biopharma Day, are pleased to announce that Epitopea is the winner of the 2023 edition. Sixteen Canadian startup companies (“Sweet 16”) selected by representatives from global pharma companies, made an elevator pitch in front of…
Laval, Canada – (BUSINESSWIRE) – 8 February 2023 – We are pleased to announce that the 3rd edition of Sweet Biopharma Day will be held, in person, on April 12, 2023. This unique, by invitation-only event invites young Canadian biotechs to submit an application for a chance to present in front of key global biopharma…
Montréal, November 17, 2022 – During the 32nd ADRIQ 2022 Innovation Awards Gala, Steven LaPlante, a researcher at INRS – Armand-Frappier Santé Biotechnologie Research Centre, and NMX Research and Solutions, a Québec contract research firm, received one of the Industrial Sectoral Research Group Awards (RSRI). Presented by CQDM, this recognition aims to highlight the role of…
MONTREAL, November 25, 2021 – The 2021 ADRIQ biopharmaceutical sector RSRI award was presented to Feldan Therapeutics, a Quebec City-based company that CQDM has been funding since 2018 as part of a collaborative research project. This project brought together a group of five major pharmaceutical companies, the Quebec biotech Feldan and academic institutions to validate…
Montréal, Canada – (BUSINESSWIRE) October 8, 2021 – AmorChem, BioQuébec and CQDM, co-organizers of Sweet Pharma Day, are pleased to announce that HDAX Therapeutics is the winner of the 2021 edition. Sixteen Canadian startup companies (“Sweet 16”) selected by representatives from global pharma companies, made an elevator pitch in front of 150+ participants, who voted…